Company: HCTI
Filing Date: 2025-02-18
Form Type: 10-K/A
Source: 0001213900-25-014503
Chunk: 117

Company: Healthcare Triangle, Inc.
Filing Date: 2025-02-18
Form: 10-K/A
Chunk 117
---
 having a relationship which, in the opinion of the Company’s Board, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. Under such definition, our Board has undertaken a review of the independence of each director. Based on information provided by each director concerning his or her background, employment and affiliations, our Board has determined that Ronald McClurg, Jainal Bhuiyan, and Dave Rosa are all independent directors of the Company. Board Committees Our board of directors has established three standing committees, audit committee, compensation committee and nominating and corporate governance committee, each of which operate under a charter that has been approved by our board of directors. We have appointed persons to the board of directors and committees of the board of directors as required meeting the corporate governance requirements of the Nasdaq Listing Rules. 53 Audit Committee We have established an audit committee consisting of Ronald McClurg, Jainal Bhuiyan, Dave Rosa and Ronald McClurg is the Chairman of the audit committee. In addition, our Board has determined that Ronald McClurg is an audit committee financial expert within the meaning of Item 407(d) of Regulation S-K under the Securities Act of 1933, as amended, or the Securities Act. The audit committee’s duties, which are specified in our Audit Committee Charter, include, but are not limited to:

| ● | reviewing and discussing with management and the independent                                                                               
 auditor the annual audited financial statements, and recommending to the board whether the audited financial statements should be included 
 in our annual disclosure report;                                                                                                           |

| ● | discussing with management and the independent auditor significant                                            
 financial reporting issues and judgments made in connection with the preparation of our financial statements; |

| ● | discussing with management major risk assessment and risk 
 management policies;                                      |

| ● | monitoring the independence of the independent auditor; |

| ● | verifying the rotation of the lead (or coordinating) audit                                                                        
 partner having primary responsibility for the audit and the audit partner responsible for reviewing the audit as required by law; |

| ● | reviewing and approving all related-party transactions; |

| ● | inquiring and discussing with management our compliance with 
 applicable laws and regulations;                             |

| ● | pre-approving all audit services and permitted non-audit                                                           
 services to be performed by our independent auditor, including the fees and terms of the services to be performed; |

| ● | appointing or replacing the independent auditor; |

| ● | determining the compensation and oversight of the work of                                                                                    
 the independent auditor (